Xeljanz XR 11 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FW31R
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,638
Award facts
- Contract value 100% obligated
- $29,638.07 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $29,638.07 delivery order to AmerisourceBergen Drug Corp for XELJANZ XR 11 MG tablets (30-count units) under a firm fixed-price contract. This delivery order, issued on December 9, 2025, with completion targeted for December 10, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems.
This award falls under AmerisourceBergen's prime Indefinite Delivery/Indefinite Quantity (IDIQ) contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which provides comprehensive pharmaceutical and medical supply support globally. The company's extensive federal contract portfolio demonstrates its capacity to supply diverse pharmaceutical products including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. XELJANZ XR is a brand-name rheumatologic treatment, consistent with AmerisourceBergen's role as a primary vendor for specialized pharmaceutical commodities supporting military healthcare requirements.
Quick answers
Who was awarded contract SPE2DR26FW31R?
SPE2DR26FW31R was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26FW31R worth?
The government has obligated $29,638 on SPE2DR26FW31R.
Is contract SPE2DR26FW31R an order under another contract?
Yes. SPE2DR26FW31R is a delivery order under SPE2DR25D3011, an indefinite delivery contract.
Was contract SPE2DR26FW31R competed?
The extent of competition for SPE2DR26FW31R was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award